Both in Pharmaceuticals
BeOne Medicines vs Mereo BioPharma Group
Over the past year ONC returned +10.2% and MREO returned −83.4%; their daily moves had a correlation of 0.08.
ONC +10.2% MREO −83.4%Growth of $1, one year, split-adjusted
| Metric | ONC | MREO |
|---|---|---|
| Price | $415.96 | $0.3050 |
| Market cap | $47.51B | $48.7M |
| Today | −0.96% | −0.52% |
| 1 month | +18.3% | −1.5% |
| 6 months | +36.6% | +24.0% |
| Year to date | +36.9% | −26.8% |
| 1 year | +21.0% | −83.7% |
| Revenue growth (YoY) | +33.8% | — |
| Gross margin | 88.5% | — |
| Net margin | 20.4% | — |
| P/E (TTM) | 51.9× | — |
| Price / sales | 7.2× | — |
| Net cash | $4.71B | — |
| Dividend yield | — | — |
| Volatility (60d) | 32.0% | 78.9% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).